Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Cut-like homeobox 2 pseudogene 1 (CUX2P1) is a human gene classified as a pseudogene, meaning it is a non-functional copy related to the cut-like homeobox 2 (CUX2) transcription factor. Pseudogenes such as CUX2P1 do not encode functional proteins and are generally considered transcriptionally silent, though some pseudogenes can have regulatory effects by acting as non-coding RNAs or affecting gene expression. CUX2P1 is not considered a molecular target for therapy, and there is no evidence suggesting involvement in disease or drug response[5]. The active gene cut-like homeobox 2 (CUX2) is a transcription factor involved in neuronal development and is part of the homeobox family, but CUX2P1 specifically designates a pseudogene, not the protein-coding gene[1][5][6][10]. There is no evidence that CUX2P1 is an actively studied or relevant molecular target in any therapeutic area. In summary, CUX2P1 is correctly annotated as a pseudogene rather than a target and should not be confused with its functional homolog, CUX2.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Cut-like homeobox 2 pseudogene 1 (CUX2P1).